Terms: = Skin cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
20 results:
1. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract] [Full Text] [Related]
2. Tryptophanyl-Transfer RNA Synthetase Is Involved in a Negative Feedback Loop Mitigating Interferon-γ-Induced Gene Expression.
Lazar I; Livneh I; Ciechanover A; Fabre B
Cells; 2024 Jan; 13(2):. PubMed ID: 38247871
[TBL] [Abstract] [Full Text] [Related]
3. Uveal melanoma: In the era of new treatments.
Wespiser M; Neidhardt E; Negrier S
Cancer Treat Rev; 2023 Sep; 119():102599. PubMed ID: 37473516
[TBL] [Abstract] [Full Text] [Related]
4. Evolving Management of Stage IV Melanoma.
Switzer B; Piperno-Neumann S; Lyon J; Buchbinder E; Puzanov I
Am Soc Clin Oncol Educ Book; 2023 Jan; 43():e397478. PubMed ID: 37141553
[TBL] [Abstract] [Full Text] [Related]
5. Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.
Wang Z; Xie Y; Wang JQ; Cheng Y; Fleishman J; Chen ZS; Chen Y
Drugs Today (Barc); 2023 Mar; 59(3):179-193. PubMed ID: 36847626
[TBL] [Abstract] [Full Text] [Related]
6. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
[TBL] [Abstract] [Full Text] [Related]
7. Tebentafusp for the treatment of hla-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Chen LN; Carvajal RD
Expert Rev Anticancer Ther; 2022 Oct; 22(10):1017-1027. PubMed ID: 36102132
[TBL] [Abstract] [Full Text] [Related]
8. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
[TBL] [Abstract] [Full Text] [Related]
9. Association Between HLA Type and skin cancer in Kidney Transplant Recipients.
Cegielska A; Dębska-Ślizień A; Moszkowska G; Imko-Walczuk B; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1608-10. PubMed ID: 27496455
[TBL] [Abstract] [Full Text] [Related]
10. Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1α in an AIM2 inflammasome-dependent manner.
Sorrentino R; Terlizzi M; Di Crescenzo VG; Popolo A; Pecoraro M; Perillo G; Galderisi A; Pinto A
Am J Pathol; 2015 Nov; 185(11):3115-24. PubMed ID: 26506473
[TBL] [Abstract] [Full Text] [Related]
11. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
Akiyama Y; Oshita C; Kume A; Iizuka A; Miyata H; Komiyama M; Ashizawa T; Yagoto M; Abe Y; Mitsuya K; Watanabe R; Sugino T; Yamaguchi K; Nakasu Y
BMC Cancer; 2012 Dec; 12():623. PubMed ID: 23270484
[TBL] [Abstract] [Full Text] [Related]
12. HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors.
Fuerst D; Parmar S; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kaechele V; Stiebel K; Paul T; Seufferlein T; Mytilineos J; Stingl JC
Pharmacogenomics; 2012 Oct; 13(13):1469-76. PubMed ID: 23057547
[TBL] [Abstract] [Full Text] [Related]
13. A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.
Nunes CT; Miners KL; Dolton G; Pepper C; Fegan C; Mason MD; Man S
Cancer Res; 2011 Aug; 71(16):5435-44. PubMed ID: 21697278
[TBL] [Abstract] [Full Text] [Related]
14. The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
Helgadottir H; Andersson E; Villabona L; Kanter L; van der Zanden H; Haasnoot GW; Seliger B; Bergfeldt K; Hansson J; Ragnarsson-Olding B; Kiessling R; Masucci GV
Cancer Immunol Immunother; 2009 Oct; 58(10):1599-608. PubMed ID: 19214504
[TBL] [Abstract] [Full Text] [Related]
15. A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.
von Euw EM; Barrio MM; Furman D; Levy EM; Bianchini M; Peguillet I; Lantz O; Vellice A; Kohan A; Chacón M; Yee C; Wainstok R; Mordoh J
J Transl Med; 2008 Jan; 6():6. PubMed ID: 18221542
[TBL] [Abstract] [Full Text] [Related]
16. HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.
Campillo JA; Martínez-Escribano JA; Muro M; Moya-Quiles R; Marín LA; Montes-Ares O; Guerra N; Sánchez-Pedreño P; Frías JF; Lozano JA; García-Alonso AM; Alvarez-López MR
Immunogenetics; 2006 Jan; 57(12):926-33. PubMed ID: 16365741
[TBL] [Abstract] [Full Text] [Related]
17. Distant metastases in ovarian carcinoma.
Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
[TBL] [Abstract] [Full Text] [Related]
18. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract] [Full Text] [Related]
19. MHC antigens in human melanomas.
Ruiter DJ; Mattijssen V; Broecker EB; Ferrone S
Semin Cancer Biol; 1991 Feb; 2(1):35-45. PubMed ID: 1912517
[TBL] [Abstract] [Full Text] [Related]
20. Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens cancer Study Group.
Leikin S; Miller D; Sather H; Albo V; Esber E; Johnson A; Rogentine N; Hammond D
Blood; 1981 Sep; 58(3):501-8. PubMed ID: 6942846
[TBL] [Abstract] [Full Text] [Related]